Back to search

Article

Single-cell RNA-sequencing reveals predictive features of response to pembrolizumab in Sézary syndrome

2022-04-02

Abstract excerpt

The PD-1 inhibitor pembrolizumab is effective in treating Sézary syndrome, a leukemic variant of cutaneous T-cell lymphoma. Our purpose was to investigate the effects of pembrolizumab on healthy and malignant T cells in Sézary syndrome and to discover characteristics that predict pembrolizumab response. Samples were analyzed before and after 3 weeks of pembrolizumab treatment by single-cell RNA-sequencing of 118,9...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
72ed597c-620d-5d11-95ed-6fbfcb672bcf
DOI
10.1101/2022.03.29.22272994
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single-cell RNA-sequencing reveals predictive features of response to pembrolizumab in Sézary syndromeDOI 10.1101/2022.03.29.22272994
Select a neighboring publication to make it the new centre.